GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
195
c/tirzepatide·posted 19 days ago by u/discount_math_dm

anyone else find 15mg genuinely unpleasant with no extra loss

Titration

Asking properly rather than in a comment on somebody else’s thread: anyone else find 15mg genuinely unpleasant with no extra loss.

Figures up front so nobody has to dig: 15mg.

Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state. Judging a new step at day five is judging noise.

It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.

Happy to answer the boring questions. Those are usually the ones worth asking.

316 up / 121 down72% upvoted25 commentsid psdxit10 Jul 2026

25 comments

17 in this archive, depth 6

best — the order this archive was captured in

u/aksel_kjaer13 points·19 days ago

SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.

replysharereportpermalink
u/crosspost_bot_no10 points·18 days ago

The thing nobody warned me about was how much of this is logistics — storing it, remembering it, the same day every week.

replysharereportpermalink
u/incretin_ivyMOD5 points·17 days ago

Left up, flair changed to Discussion. It is an opinion post and that is fine as long as it is labelled.

replysharereportpermalink
u/zeynep_zielinski3 points·17 days ago

SURMOUNT-1 landed around 21% at 72 weeks on the top arm

replysharereportpermalink
u/gustav_vermeulen6 points·17 days ago

Careful with "everyone tolerates it better". The people it did not suit stop posting, which makes this board look calmer than the drug is.

replysharereportpermalink
[removed]4 points·17 days ago

[removed by moderator]

replysharereportpermalink
u/customs_seizure_sid8 points·17 days ago

Held 7.5 for five months. Everyone kept asking when I was going to 10. The answer was never, because 7.5 was working.

replysharereportpermalink
u/ghrp_history5 points·18 days ago

Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.

replysharereportpermalink
u/discount_math_dmOP2 points·18 days ago

the four-week step schedule is the label, not folklore

replysharereportpermalink
u/discount_math_dm1 point·18 days ago

Not sure that follows. You went up a step and changed your training in the same fortnight.

replysharereportpermalink
u/discount_math_dmOP1 point·18 days ago

Correction to my own post above — I said 5mg and I have been on 7.5mg since the spring. Same argument, wrong number.

replysharereportpermalink
u/discount_math_dmOP1 point·18 days ago

What step are you on and how long have you been there?

replysharereportpermalink
u/curious_panel_only1 point·17 days ago

Same experience with the appetite effect being flatter across the week rather than front-loaded.

replysharereportpermalink
u/yusuf_ramos1 point·18 days ago

Are you comparing yourself with the trial mean or with the people who post the most?

replysharereportpermalink
u/tove_vasquez1 point·18 days ago·edited

Went 10 to 12.5 on the calendar and had the worst fortnight of the whole run. Dropped back to 10 and everything settled.

replysharereportpermalink
u/vito_chowdhury4 points·18 days ago

Week 15 was the first time the scale moved after a five-week stall. I changed nothing in that window.

replysharereportpermalink
u/laila_yilmaz-12 points·18 days ago

2.5 is the starter dose and it is not meant to be the dose that works

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.